@article{lazar2022transcriptomics,
  title={Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non--Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant Therapies},
  author={Lazar, Vladimir and Girard, Nicolas and Raymond, Eric and Martini, Jean-Fran{\c{c}}ois and Galbraith, Susan and Raynaud, Jacques and Bresson, Catherine and Solomon, Benjamin and Magidi, Shai and Nechushtan, Hovav and others},
  journal={JCO Precision Oncology},
  volume={6},
  pages={e2200072},
  year={2022},
  publisher={Wolters Kluwer Health}
}

{"_id":"f9HfW79H22BWehnK4","bibbaseid":"lazar-girard-raymond-martini-galbraith-raynaud-bresson-solomon-etal-transcriptomicsintumorandnormallungtissuesidentifypatientswithearlystagenonsmallcelllungcancerwithhighriskofpostsurgeryrecurrencewhomaybenefitfromadjuvanttherapies-2022","author_short":["Lazar, V.","Girard, N.","Raymond, E.","Martini, J.","Galbraith, S.","Raynaud, J.","Bresson, C.","Solomon, B.","Magidi, S.","Nechushtan, H.","others"],"bibdata":{"bibtype":"article","type":"article","title":"Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non–Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant Therapies","author":[{"propositions":[],"lastnames":["Lazar"],"firstnames":["Vladimir"],"suffixes":[]},{"propositions":[],"lastnames":["Girard"],"firstnames":["Nicolas"],"suffixes":[]},{"propositions":[],"lastnames":["Raymond"],"firstnames":["Eric"],"suffixes":[]},{"propositions":[],"lastnames":["Martini"],"firstnames":["Jean-François"],"suffixes":[]},{"propositions":[],"lastnames":["Galbraith"],"firstnames":["Susan"],"suffixes":[]},{"propositions":[],"lastnames":["Raynaud"],"firstnames":["Jacques"],"suffixes":[]},{"propositions":[],"lastnames":["Bresson"],"firstnames":["Catherine"],"suffixes":[]},{"propositions":[],"lastnames":["Solomon"],"firstnames":["Benjamin"],"suffixes":[]},{"propositions":[],"lastnames":["Magidi"],"firstnames":["Shai"],"suffixes":[]},{"propositions":[],"lastnames":["Nechushtan"],"firstnames":["Hovav"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["others"],"suffixes":[]}],"journal":"JCO Precision Oncology","volume":"6","pages":"e2200072","year":"2022","publisher":"Wolters Kluwer Health","bibtex":"@article{lazar2022transcriptomics,\n title={Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non--Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant Therapies},\n author={Lazar, Vladimir and Girard, Nicolas and Raymond, Eric and Martini, Jean-Fran{\\c{c}}ois and Galbraith, Susan and Raynaud, Jacques and Bresson, Catherine and Solomon, Benjamin and Magidi, Shai and Nechushtan, Hovav and others},\n journal={JCO Precision Oncology},\n volume={6},\n pages={e2200072},\n year={2022},\n publisher={Wolters Kluwer Health}\n}\n\n","author_short":["Lazar, V.","Girard, N.","Raymond, E.","Martini, J.","Galbraith, S.","Raynaud, J.","Bresson, C.","Solomon, B.","Magidi, S.","Nechushtan, H.","others"],"key":"lazar2022transcriptomics","id":"lazar2022transcriptomics","bibbaseid":"lazar-girard-raymond-martini-galbraith-raynaud-bresson-solomon-etal-transcriptomicsintumorandnormallungtissuesidentifypatientswithearlystagenonsmallcelllungcancerwithhighriskofpostsurgeryrecurrencewhomaybenefitfromadjuvanttherapies-2022","role":"author","urls":{},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/network/files/QpppF92hGWuJ5y5Eh","dataSources":["cDE3DgNwWaCuHMBJA","tZGdDTGBDgYLaWmis","u6vCg6hdprqERxouE","tpPgfZjgEFYmWeP27","B5khaFiqcrF2ex5G6"],"keywords":[],"search_terms":["transcriptomics","tumor","normal","lung","tissues","identify","patients","early","stage","non","small","cell","lung","cancer","high","risk","postsurgery","recurrence","benefit","adjuvant","therapies","lazar","girard","raymond","martini","galbraith","raynaud","bresson","solomon","magidi","nechushtan","others"],"title":"Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non–Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant Therapies","year":2022}